This study demonstrated the association of echocardiographic dyssynchrony with long-term survival after cardiac resynchronization therapy (CRT). The authors studied 229 consecutive patients with routine CRT indications (symptomatic heart failure, reduced ejection fraction, and widened QRS ≥120 ms), of whom 210 (89%) had baseline echocardiographic dyssynchrony data available. Dyssynchrony was prespecified as tissue Doppler longitudinal velocity opposing-wall delay ≥65 ms, 12-site SD (Yu Index) ≥32 ms, speckle tracking radial strain anteroseptal-to-posterior wall delay ≥130 ms, or pulsed Doppler interventricular mechanical delay ≥40 ms. Of 210 patients, there were 62 unfavorable events over 4 years after CRT: 47 deaths, 9 transplantations, and 6 left ventricular assist device implantations. All echocardiographic dyssynchrony indexes were significantly associated with a more favorable long-term prognosis than for patients without dyssynchrony, except tissue Doppler velocity opposing-wall delay became significant at ≥80 ms. When adjusted for covariates of ischemic pathogenesis and QRS width, the Yu Index and speckle tracking radial strain remained independently predictive of outcome. Subgroup analysis demonstrated that patients with narrower QRS width of 120 to 150 ms, who lacked radial dyssynchrony, had a particularly poor survival. Although this study has identified the absence of echocardiographic dyssynchrony as a marker for a less favorable prognosis in patients who undergo CRT for routine indications, the potential influence of CRT on outcome in patients without dyssynchrony remains unknown. These observations strongly support the association of echocardiographic dyssynchrony with longterm patient outcome after CRT.
Summary:
The beneficial effects of cardiac resynchronization therapy on long-term survival are influenced by several pathophysiological factors. The present study demonstrated the relative merits of left ventricular (LV) dyssynchrony, LV lead position, and myocardial scar to predict long-term outcome of ischemic heart failure patients treated with cardiac resynchronization therapy. With speckle tracking radial strain analysis, the extent of LV dyssynchrony, site of latest mechanical activation, and presence of myocardial scar at the LV segment where the LV pacing lead is placed were evaluated. In addition, the LV lead position was derived from chest x-ray and was defined as concordant when the LV pacing lead coincided with the site of latest mechanical activation. Mean baseline LV radial dyssynchrony was 133±98 ms. A concordant LV lead position was reported in 271 patients (68%), and the mean value of peak radial strain at the targeted segment was 18.9±12.6%. During a median follow-up of 21 months, 88 patients (22%) died. Larger LV radial dyssynchrony at baseline was an independent predictor of superior long-term survival (hazard ratio, 0.995 per 1-ms increment; P=0.001), whereas a discordant LV lead position (hazard ratio, 2.086; P=0.001) and myocardial scar in the segment targeted by the LV lead (hazard ratio, 2.913; P<0.001) were independent predictors of worse outcome. Addition of these 3 parameters yielded incremental prognostic value over the combination of clinical parameters. These data underscore the need for integrated evaluation that includes assessment of these 3 parameters to further improve patient selection and survival after cardiac resynchronization therapy.
Conclusions: Baseline LV radial dyssynchrony, discordant LV lead position, and myocardial scar in the region of the LV pacing lead were independent determinants of long-term prognosis in ischemic heart failure patients treated with cardiac resynchronization therapy. Larger baseline LV dyssynchrony predicted superior long-term survival, whereas discordant LV lead position and myocardial scar predicted worse outcome.
Editor's Comment: The efficacy of cardiac resynchronization therapy is diminished in the setting of coronary artery disease. In addition to mechanical dyssynchrony at baseline, identification of myocardial regions with the latest mechanical activation and/or scar have emerged as potentially important determinants of the response to cardiac resynchronization therapy. In this study, the absence of dyssynchrony, and the placement of the LV pacing lead in either myocardium without the most delayed mechanical activation (so-called discordant placement) or with frank evidence of scar were independently associated with worse clinical outcomes (death and hospitalization for heart failure). In multivariable modeling, all 3 imaging parameters provided incremental information to preimaging variables. Although the data provide intriguing mechanistic insights into the relationship between cardiac resynchronization therapy and improved outcomes, the approach warrants prospective evaluation of the integrated imaging approach. 2
Association Between Aneurysm Shoulder Stress and Abdominal Aortic Aneurysm Expansion: A Longitudinal Follow-Up Study
Summary: By convention, abdominal aortic aneurysm (AAA) diameter has been used as an indicator of the potential risk of rupture. Advances in biomechanics have enabled us to assess the inherent stresses within the aneurysm wall, which are thought to play a role in aneurysm expansion. From the structural view point, aneurysm expansion and rupture results from material fatigue and failure of the aneurysm wall. In this study, the authors assessed the association of AAA wall stresses with their expansion rates and found that stresses at the shoulder of the rapidly expanding aneurysms had good correlation with the expansion rates compared with slowly expanding aneurysms. The authors also tested the relationship of maximum diameter of the aneurysm to its expansion rate, but although such a relationship is widely believed to exist, they found no such relationship. This highlights the fact that biomechanical stress analysis of AAAs may be useful for estimating their expansion rather than relying only on maximum AAA diameter for assessment of potential risk of rupture.
Conclusions: A higher shoulder stress was found to have an association with a rapidly expanding AAA. Therefore, it may be useful for estimating the expansion of AAAs and improve risk stratification of patients with AAAs.
Editor's Comment: The maximum diameter and expansion rate of AAA are clearly linked to the risk of rupture and, thus, established criteria for AAA repair. Patients with AAA without an indication for repair (<5.5 cm) may also be at risk for complications, but risk stratification in this setting is more challenging. This study provides evidence that increased wall stress, as derived from computed tomography angiography of the abdominal aorta, at the aneurysm shoulder was associated with increased expansion rate. This adds to the emerging interest in advanced imaging, including molecularly targeted approaches, for improving risk prediction and potentially improving the timing of interventions in patients who do not meet criteria for AAA repair. 3 
Magnetic Resonance Imaging of Carotid Atherosclerotic Plaque in Clinically Suspected Acute Transient Ischemic Attack and Acute Ischemic Stroke
Summary: Ischemic stroke is a major source of morbidity and mortality in aging populations. The majority of ischemic stroke and precursor events of transient ischemic attack are cryptogenic, and therefore the medical management options for patients who have suffered transient ischemic attack/ischemic stroke are severely limited. Even after a full acute stroke/transient ischemic attack medical workup, clinicians are often left with no treatable source for the event and are therefore limited to risk factor modification and optimization of medical treatments for diabetes mellitus, hypertension, and hyperlipidemia in patients who are at high risk for subsequent events. Atherosclerosis at the carotid bifurcation is likely the major cause for transient ischemic attack/ischemic stroke. The methods to detect critical atherosclerotic disease have essentially been limited to the identification of severely stenotic lesions via lumenography for the last 50 years. Stenotic lesions are uncommon, and a large number of critical lesions are likely being missed because of limitations of atherosclerosis lesion detection and characterization. Through noninvasive magnetic resonance imaging of the vessel wall, both stenotic and nonstenotic American Heart Association type VI atherosclerotic plaque demonstrating intramural hemorrhage, cap rupture, and/or thrombosis in situ can be identified. These type VI lesions are the likely cause for cerebral thromboembolism as supported by the leading scientific models of thromboembolic stroke. If critical lesions can be identified, there is an opportunity for medical, surgical, or endovascular treatments of the patients who would benefit most. Furthermore, there would be an opportunity to monitor response to treatment. The potential clinical impact of magnetic resonance imaging of vulnerable carotid bifurcation atherosclerosis is great.
Conclusions:
In situ type VI carotid bifurcation region plaque identified by magnetic resonance imaging is associated with ipsilateral acute transient ischemic attack/ischemic stroke as an independent identifier of events, thereby supporting the dominant disease pathophysiology.
Editor's Comment: The degree of luminal narrowing in the carotid arteries have been the cornerstone of risk stratification and management decisions of patients at risk of ischemic stroke or transient ischemic attack. However, it is now clear that stenosis dimensions alone do not account for the excess risk in many of these patients. This study used high resolution magnetic resonance imaging to delineate features of atherosclerotic carotid plaques and their association with thromboembolic events in acutely ill patients presenting with symptoms of acute transient ischemic attack or stroke. The study shows a significant association between plaques demonstrating intramural hemorrhage, cap rupture, or thrombosis and ipsilateral transient ischemic attack or ischemic stroke as defined by brain MRI. This adds to a growing body of evidence supporting the potential role of advanced imaging for improved identification of at-risk patients, which may potentially improve management decisions. 4
Comparative Effectiveness of Exercise Electrocardiography With or Without Myocardial Perfusion Single Photon Emission Computed Tomography in Women With Suspected Coronary Artery Disease: Results From What Is the Optimal Method for Ischemia Evaluation in Women (WOMEN) Trial
Summary: There is a paucity of prospective, randomized trials as well as a compelling need for higher levels of scientific evidence, including targeted, prospective comparative effectiveness research, to more rigorously address the outpatient diagnostic evaluation of patients with suspected coronary artery disease. In particular, the evaluation of women with suspected coronary artery disease remains a conundrum because of their atypical symptom presentation, which often results in varied diagnostic practice patterns. What Is the Optimal Method for Ischemia Evaluation in Women trial was designed to compare the effectiveness of the standard exercise tolerance test (ETT) with exercise myocardial perfusion imaging (MPI) for predicting 2-year event-free survival for women with suspected coronary artery disease at intermediate pretest coronary artery disease likelihood who are capable of performing exercise. A total of 824 women were randomized to a standard ETT or exercise MPI. At 2 years, there was no difference in major adverse cardiovascular events (ETT, 98.0%; MPI, 97.7%; P=0.59). Compared with ETT alone, index testing costs were higher for the exercise MPI group (P<0.001), whereas downstream procedural costs were slightly lower (P=0.008). Overall, the cumulative diagnostic cost saving was 48% for the ETT compared with the exercise MPI group (P<0.001).
In conclusion, in low-risk, symptomatic women capable of exercise, a nonimaging strategy employing standard ETT was as effective in predicting clinical outcomes and more cost-efficient than a strategy of initial exercise MPI.
Conclusions:
In low-risk, exercising women, a diagnostic strategy that uses ETT versus exercise MPI yields similar 2-year posttest outcomes while providing significant diagnostic cost savings. The ETT with selective follow-up testing should be considered as the initial diagnostic strategy in symptomatic women with suspected coronary artery disease.
Editor's Comment: This is an important comparative effectiveness study evaluating the efficacy exercise treadmill testing (ETT alone) without imaging and exercise radionuclide MPI for risk stratification of symptomatic women at low-intermediate clinical risk. The study demonstrated no difference in short-term outcomes between the 2 strategies. Importantly, the ETT-alone strategy with selective follow-up imaging for patients with nondiagnostic stress tests resulted in significant cost-savings while also allowing to reduce the low but potential risks of radiation. 5
Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve
Summary: Quantitative estimates of myocardial blood flow and coronary flow reserve integrate the fluid dynamic effects of epicardial atherosclerosis and microvascular function. The present study demonstrates that coronary flow reserve improves stratification of risk of cardiac and all-cause mortality beyond clinical risk factors, left ventricular ejection fraction, extent of myocardial ischemia and scar, and stress-induced left ventricular ejection fraction augmentation. Patients with coronary flow reserve <1.5 were at 5.6-fold increased risk of cardiac mortality compared with those with coronary flow reserve >2.0. Among patients whose clinical risk factors, left ventricular ejection fraction, and stress imaging findings placed them at intermediate risk of cardiac death (1-3% per year), 35% were reclassified as either high risk (>3% cardiac mortality per year) or low risk (<1% cardiac mortality per year). These findings demonstrate that incorporation of coronary vasodilator function assessment into stress testing by quantification of coronary flow reserve improves risk stratification in patients with known or suspected coronary artery disease.
Conclusions: Noninvasive quantitative assessment of coronary vasodilator function with positron emission tomography is a powerful, independent predictor of cardiac mortality in patients with known or suspected coronary artery disease, and provides meaningful incremental risk stratification over clinical and gated myocardial perfusion imaging variables.
Editor's Comment: Coronary circulatory dysfunction is present in the earliest stages of atherogenesis and precedes significant angiographic stenosis, identifiable perfusion deficits, and wall motion abnormalities with traditional imaging methods. These data from a large patient cohort demonstrates the powerful incremental prognostic value of noninvasive measures of coronary flow reserve (peak/ rest myocardial blood flow) over the combination of comprehensive clinical assessment, left ventricular ejection fraction, and semiquantitative measures of myocardial ischemia and scar for identification of patients at risk of cardiac mortality. The study demonstrates that the addition of coronary flow reserve information to a comprehensive predictive risk model results in the reclassification of 25% of patients across clinically relevant risk categories. These quantitative measures of coronary flow reserve can be obtained at no additional cost, imaging time, or radiation exposure. The study is important as it demonstrates for the first time that all reclassified patients were placed into more accurate risk categories, suggesting that the postcoronary flow reserve risk estimates presented here may impact patient management by triggering more targeted management of risk factors or referral for revascularization. 6
Impact of Loading Condition on the 2D Speckle-Tracking-Derived Left Ventricular Dyssynchrony Index in Nonischemic Dilated Cardiomyopathy
Summary: Despite excellent results regarding use of cardiac resynchronization therapy, a treatment for restoring left ventricular (LV) synchronous contraction in patients with drug-refractory heart failure, approximately 30% of patients do not respond to this sophisticated treatment, underscoring the need for better selection criteria. Echocardiographic LV dyssynchrony index has recently been proposed as a better surrogate for predicting positive cardiac resynchronization therapy responders. Heart failure is considered a dynamic condition because LV loading status can be changed by a variety of medications used to improve patient symptoms. To date, however, there are few data concerning the potential influence of LV loading status on the echocardiographic assessment of LV dyssynchrony. The authors investigated the effect of LV loading condition on LV dyssynchrony in patients with nonischemic dilated cardiomyopathy using speckle-tracking-derived radial strain echocardiography. The measurement of LV dyssynchrony in this study (the maximal difference in time-to-peak radial strain in 2 or 6 segments as well as SD of the time-to-peak radial strain for 6 segments) were significantly affected by changes in LV loading conditions created by sublingual nitroglycerin administration and pneumatic lower extremity compression. In particular, using 130 ms of difference between the anteroseptal and inferolateral segment as a cutoff value for the presence of LV dyssynchrony, the proportion of patients with LV dyssynchrony significantly changed (29.7% at baseline, 45.9% under pneumatic lower extremity compression, and 35.1% after sublingual nitroglycerin administration). Therefore, LV loading conditions should be considered when echocardiographic assessment of LV dyssynchrony is used for clinical decision-making.
Conclusions:
To the best of the authors' knowledge, the present study provides the first evidence of a significant association between LVdys and LV loading status, reflective of a dynamic nature of LVdys. Accordingly, LV loading conditions should be taken into account when echocardiographic LVdys is used for clinical decision-making of selecting candidates for cardiac resynchronization therapy or when it is used as a surrogate marker of prognosis.
Editor's Comment: Controversy remains to be the optimal technique to assess LV dyssynchrony, and studies have provided conflicting results about outcome prediction. Much of the difficulty relates to reproducibility of the measurements, variable indices proposed, and the fact that a sizeable number of seemingly appropriate individuals do not respond to resynchronization therapy. This small study provides another wrinkle in demonstrating that modification of preload or afterload influence 2D speckle-tracking-derived LV dyssynchrony in patients with nonischemic cardiomyopathy. None of this is particularly surprising, but it is another piece of evidence that we need more definitive, robust metrics to assess dyssynchrony, and that it e42 Circ Cardiovasc Imaging July 2012 is of more importance to define parameters that will reliably predict outcome. 7
Prognostic Value of Right Ventricular Function in Patients After Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
Summary: The prognosis of patients after acute myocardial infarction is determined by the interaction of a large number of factors.
Besides the importance of clinical parameters, several studies have described the importance of left ventricular function as one of the most important prognostic parameters. However, data on the association between right ventricular (RV) function and adverse events after acute myocardial infarction are scarce. In the current study, the prognostic value of RV function in 612 consecutive patients admitted with acute myocardial infarction and treated with primary percutaneous coronary intervention, who underwent echocardiography within 48 hours of admission, was evaluated. RV function was quantified with RV fractional area change, tricuspid annular plane systolic excursion, and RV strain. During a mean follow-up of 24 months, 86 patients reached the end point defined as a composite of all-cause mortality, reinfarction, and hospitalization for heart failure. RV fractional area change (hazard ratio, 0.96; 95% CI, 0.92-0.99) and RV strain (hazard ratio, 1.08; 95% CI, 1.03-1.13) were both independent predictors of the composite end point. In addition, RV strain provided incremental value to baseline clinical information, infarct characteristics, left ventricular function, and RV fractional area change for the prediction of the composite end point.
Conclusions:
RV function provides strong prognostic information in patients treated with primary percutaneous coronary intervention for acute myocardial infarction.
Editor's Comment: Numerous studies in the past have demonstrated the prognostic importance of RV infarction or dysfunction in patients with acute myocardial infarction. This moderate-sized prospective study is unique in that it includes only patients undergoing percutaneous coronary intervention and who had different types of assessment of RV function within 48 hours after myocardial infarction and percutaneous coronary intervention. The novel contribution is that RV strain provides incremental value over clinical information, myocardial infarction characteristics, left ventricular function, and RV fractional area change in predicting the composite end points of mortality, recurrent myocardial infarction, and hospitalization for heart failure. This single time-point assessment is a useful new piece of information, and further assessment on how changes over time will impact the findings may be helpful in modifying treatment for these patients. 8
Effects of Mitral Valve Surgery on Myocardial Energetics in Patients With Severe Mitral Regurgitation
Summary: Hemodynamically significant mitral regurgitation (MR) may alter left ventricular (LV) myocardial energy requirements. The effects of MR and subsequent corrective mitral valve (MV) surgery on myocardial energetics are not well understood. A better understanding of myocardial energetics and the LV responses to changes in preload and afterload may assist with the understanding of MR and its effect on the LV. The authors sought to determine the effects of MV surgery on forward stroke work, myocardial oxidative metabolism, and myocardial efficiency. Prospectively enrolled patients with chronic, severe, nonischemic MR underwent echocardiography, radionuclide angiography, and C-11 acetate positron emission tomography to measure LV volumes, ejection fraction, oxidative metabolism, and work metabolic index before and 1 year after MV surgery. One year after MV surgery, there was a reduction in LV end-diastolic and end-systolic volumes, preservation of LV ejection fraction, and a conservation of total work metabolic index.
Conclusions: MV surgery has a beneficial effect on forward stroke volume and forward work metabolic index without adverse effects on oxidative metabolism or total work metabolic index.
Editor's Comment: This relatively small but elegant study utilizes echocardiography, radionuclide angiography, and C-11 acetate positron emission tomography to measure LV volumes, ejection fraction, and oxidative metabolism before surgery for severe nonischemic MR and at follow up 1 year later. As shown in previous studies, LV volumes decrease, as does forward stroke volume, but the new information is that this occurs, in these patients, without an adverse effect on oxidative metabolism. This study brings the practical application of myocardial efficiency to clinical scenarios and demonstrates the applicability of work metabolic index to evaluation of interventions. The study was not designed to stratify patients for MV surgery and this would need to be tested in appropriately designed trials. 9
PET Imaging May Provide a Novel Biomarker and Understanding of Right Ventricular Dysfunction in Patients With Idiopathic Pulmonary Arterial Hypertension
Summary: This is a comprehensive study in patients with idiopathic pulmonary arterial hypertension (New York Heart Association functional class I/II). All patients underwent magnetic resonance imaging, right heart catheterization, quantification of myocardial blood flow, quantification of myocardial glucose uptake, and cardiopulmonary exercise testing. The study revealed that PET scanning with 13 N-NH 3 and 18 F-fluorodeoxyglucose appears to be a feasible modality for quantifying right ventricular (RV) blood flow and RV metabolism in patients with idiopathic pulmonary hypertension. An increased metabolic rate of glucose uptake in the RV presumably indicates early RV functional impairment. The shift in myocardial glucose uptake may be an early marker of RV dysfunction and possibly a preclinical marker before overt RV failure given that RV function on magnetic resonance imaging in the current study was largely preserved and that most patients were in New York Heart Association functional class I/ II. The relations observed support the need for further investigation of myocardial glucose uptake as a novel early biomarker that could be a therapeutic target in the treatment and monitoring of pulmonary arterial hypertension. In addition, the study demonstrates a trend toward negative correlation with maximum oxygen consumption, suggesting that this finding may have some prognostic impact. Maximum oxygen consumption is considered a strong predictor of survival in patients with pulmonary arterial hypertension. Monitoring myocardial glucose uptake level may help to optimize treatment to improve function and outcome.
Conclusions: Positron emission tomography scanning with 13 N-NH 3 and 18 F-fluorodeoxyglucose is a feasible modality for quantifying RV blood flow and metabolism in patients with idiopathic pulmonary arterial hypertension.
Editor's Comment: Reliable and reproducible quantitative assessment of RV function remains a clinical and imaging challenge. In this small study, the authors utilize PET scanning in patients with idiopathic pulmonary arterial hypertension and demonstrate the methods for assessing RV blood flow and RV metabolism. The relationship of these parameters to progression of disease, RV dysfunction, and functional capacity still need to be determined. If the metabolic changes are linked to disease and disease progression, there is real potential for these parameters to be utilized for therapeutic intervention assessment. 10
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Vascular Inflammation in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus: Analysis With
18
F-Fluorodeoxyglucose Positron Emission Tomography
Summary: Inflammatory atherosclerotic plaque has been established as a main contributing factor responsible for cardiovascular disease. Type 2 diabetes mellitus is not only an independent risk factor for atherosclerotic cardiovascular disease but is also associated with increased levels of inflammatory markers. There is growing, consistent evidence that quantitative positron emission tomography with 18 F-deoxyglucose can provide a noninvasive measure of vascular inflammation. In this study, the authors found increased 18 F-deoxyglucose uptake in patients with impaired glucose tolerance and type 2 diabetes mellitus compared with the healthy subjects, even though there were no significant differences in the carotid intima-media thickness across the groups. This result suggests that vascular inflammation detected by positron emission tomography with 18 F-deoxyglucose may reflect an earlier stage in atherogenesis that is manifested before anatomic changes can be detected by ultrasonography.
Conclusions:
The results of the present study suggest that impaired glucose tolerance and type 2 diabetes mellitus are associated with vascular inflammation in carotid atherosclerosis detected by fluorodeoxyglucose positron emission tomography.
Editor's Comment: There have been numerous imaging studies recently attempting to evaluate local arterial inflammation in small vessels as well as large. These assessments often attempt to correlate with plaque vulnerability and there are methodologic challenges. This cross-sectional case control study uses positron emission tomography/computed tomography imaging to assess right carotid inflammation in control patients, patients with impaired glucose tolerance, and patients with type 2 diabetes mellitus. It demonstrates increased target to background ratio in the noncontrol patients suggestive of inflammation. There is no gold standard and there is some correlation with biomarkers. If supported by future study, this could be utilized to evaluate outcome on the basis of the presence and magnitude of inflammation and impact of interventions. 11
Carotid Plaque Inflammation Is Associated With Cerebral Microembolism in Patients With Recent Transient Ischemic Attack or Stroke: A Pilot Study
Summary: Cerebral infarcts distal to carotid stenoses are thought to be caused by emboli from inflamed, destabilized plaques. The authors hypothesized that microembolic signals (MES) on transcranial Doppler will be associated with carotid plaque inflammation on 18 F-fluorodeoxyglucose positron emission tomography (FDG PET) in recently symptomatic patients. Sixteen patients presenting with recent (47±31 days) anterior circulation transient ischemic attack or minor stroke and 50 to 99% stenosis of the ipsilateral carotid bifurcation underwent FDG PET, high-resolution black-blood carotid magnetic resonance imaging, and transcranial Doppler for detection of MES.
Patients with potential cardiac sources of emboli or contralateral MES were excluded. Regions of interest defined on the coregistered magnetic resonance imaging were used to measure FDG standardized uptake values (with Rousset partial volume correction) from the index and contralateral carotid plaques and artery. Ipsilateral MES were detected in 7 patients (MES+ group) and absent in 8 (MES− group). There was a significant difference in index-to-contralateral plaque standardized uptake value ratio between MES+ (median, 1.05; first to third quartile, 0.96-1.32) and MES− (median, 0.76; first to third quartile, 0.62-0.94) patients (P=0.005). The interval from symptom onset to PET and percent index carotid stenosis were not different between the 2 groups (P=0.68 and P=0.48, respectively).
Conclusions:
In this sample of recently symptomatic patients with carotid stenosis, an association was found between in vivo measures of plaque inflammation detected by FDG PET and the presence of transcranial Doppler MES. These findings strengthen the notion that embolic events distal to carotid stenoses are related to plaque inflammation, and FDG PET may be useful in the investigation of culprit carotid lesions.
Editor's Comment: This study extends assessment of carotid inflammation measured by FDG PET from the descriptive to clinical events. The cohort of 16 patients comprises individuals with a recent small stroke or transient ischemic attack and carotid stenosis. The authors demonstrate an association between the degree of inflammation in the ipsilateral carotid artery and Doppler derived MES. Although the study is small and not a true outcomes study, it does demonstrate clinical correlation with the PET findings of inflammation and brings metabolic imaging closer to clinical decision-making and targeted intervention. 12
Abdominal Aortic Aneurysm Growth Predicted by Uptake of Ultrasmall Superparamagnetic Particles of Iron Oxide: A Pilot Study
Summary: Abdominal aortic aneurysm (AAA) rupture is a catastrophic event associated with a very high mortality rate. Patients with known AAA are therefore enrolled in a surveillance program involving serial ultrasound scanning to monitor changes in aneurysm diameter, taken as a surrogate for risk of rupture. Patients with an aneurysm >5.5 cm in diameter are perceived to be at high risk and are offered surgical or endovascular aneurysm repair. Although AAA diameter is the best predictor of rupture currently available, up to 20% of ruptured AAA are <5.5 cm. Large studies have shown no mortality benefit for early surgery over continued surveillance in this group of patients. Conversely, many patients have AAA considerably larger than 5.5 cm without rupture. We therefore need an improved method of predicting rupture for individual patients. Rupture is thought to occur in regions of the aortic wall featuring intense inflammation and proteolytic activity. We used magnetic resonance imaging with a novel contrast agent consisting of ultrasmall superparamagnetic particles of iron oxide (USPIO) to identify focal inflammation within the aortic wall. The key finding is that USPIO uptake within the aortic wall was associated with a rate of aneurysm expansion (0.66 cm/y) 3-fold higher than AAA with no mural USPIO uptake. If confirmed in larger longitudinal studies, these results suggest that USPIO-enhanced magnetic resonance imaging may be a more accurate way to predict disease progression than diameter alone in patients with AAA, facilitating selection of patients for preventative surgery.
Conclusions: Uptake of USPIO in AAA identifies cellular inflammation and appears to distinguish those patients with more rapidly progressive AAA expansion. This technique holds major promise as a new method of risk-stratifying patients with AAA that extends beyond the simple anatomic measure of aneurysm diameter.
Editor's Comment: Elective intervention for AAA is based on the size of the aneurysm and the theory behind this is related to wall stress and likelihood of rupture. It is well known that the rate of expansion varies quite widely and that in some patients unexpected catastrophic events occur. Metabolic markers and different imaging techniques have been tested over the years to attempt to stratify patients. In this study, 29 patients were studied with a 3 T magnetic resonance imaging scanner after administration of USPIO and correlated with histology at surgery in those patients who underwent surgery soon after the imaging. The changes in T2* value correlate with cellular inflammation and appear to differentiate patients with a tendency to more rapidly progressive growth of the aortic aneurysm. This study is consistent with others using superparamagnetic particles of iron oxide and may prove useful in following and triaging patients with large vessel aneurysms. 13
Hemodynamic Improvement in Cardiac Resynchronization Does Not Require Improvement in Left Ventricular Rotation Mechanics: Three-Dimensional Tagged Magnetic Resonance Imaging Analysis
Summary: Left ventricular (LV) rotation mechanics provide important indices of cardiac function. Earlier studies have yielded conflicting evidence on whether or not cardiac resynchronization therapy (CRT) improves LV rotation mechanics. This discrepancy may arise from technical and interpretative limitations of the 2-dimensional echocardiography that was used in those studies. In the present study, the authors sought to study the acute effects of CRT on LV rotation mechanics by 3-dimensional tagged magnetic resonance imaging in dogs with left bundle branch block (LBBB) and tachycardia-induced cardiomyopathy. Three-dimensional tagged magnetic resonance imaging is the gold standard technique to measure myocardial motion in vivo, and it allows objective and extensive mapping of the 3-dimensional displacement field within the left ventricle. The results of this study indicate that CRT acutely improves hemodynamic parameters without improving LV rotation mechanics. This suggests that improvement in LV rotation mechanics appears to be a specific but insensitive index of an acute hemodynamic response to CRT.
Conclusions: CRT acutely improves hemodynamic parameters without improving LV rotation mechanics. There is no significant circumferential regional heterogeneity of LV rotation mechanics in the mechanically dyssynchronous heart. These results suggest that LV rotation mechanics is an index of global LV function, which requires coordination of all regions of the left ventricle, and improvement in LV rotation mechanics appears to be a specific but insensitive index of acute hemodynamic response to CRT.
Editor's Comment: In this animal study, the authors use a canine model of LBBB with pacing induced cardiomyopathy to explore the relation between acute improvement in LV systolic function (as determined by several hemodynamic parameters) and changes in LV rotation/rotation rate and torsion/torsion rate. They report acute hemodynamic improvement without changes in any of the rotation parameters noting apex to base but not circumferential heterogeneity in rotation mechanics at baseline or after CRT. This study furthers our understanding of the impact of CRT on LV function though note should be made that the model may not be representative of function in humans with ischemic cardiomyopathy. 14
Pulmonary Vascular Resistance, Collateral Flow, and Ventricular Function in Patients With a Fontan Circulation at Rest and During Dobutamine Stress
Summary: The pathophysiologic causes for failure of the Fontan circulation are multifactorial. Therefore, diagnostic tools are warranted that permit a differential analysis of ventricular and pulmonary vascular function. In this study, an magnetic resonance imaging catheterization technique that enables simultaneous pressure and volume measurement in the single ventricle was used. From these measurements, parameters of global pump, myocontractile, and diastolic function can be derived. In addition, magnetic resonance imaging catheterization allows determination of aortopulmonary collateral flow in conjunction with pulmonary vascular resistance. The authors found that pharmacological stress by dobutamine improved contractility, although without substantial augmentation of stroke volumes. At the same time, the single ventricle showed signs of abnormal diastolic performance. In the absence of a subpulmonary ventricle, these findings should be seen in light of pulmonary vascular function. In the studied patients, blood flow through aortopulmonary collaterals contributed substantially to the total pulmonary blood flow. In addition, its proportion increased during stress. However, augmented total pulmonary blood flow was not associated with increased pulmonary vascular resistance, implying that resistance did not contribute to a limited preload reserve and, thus, impaired diastolic filling of the systemic ventricle. The method described in this study provides detailed and differential information of the cardiovascular function in Fontan, which will potentially improve the planning of individual treatment strategies. The findings of this descriptive study of preselected patients require further study in larger groups of patients with different types of Fontan circulation.
Conclusions:
In patients with a Fontan circulation, aortopulmonary collateral flow contributes substantially to enhanced pulmonary flow during stress. The authors' data indicate that pulmonary vascular response to augmented cardiac output was adequate, but decreased diastolic compliance was identified as an important component of ventricular dysfunction.
Editor's Comment: In this study, 10 Fontan patients preselected on the basis of reduced exercise tolerance underwent combined magnetic resonance imaging/invasive assessment of ventricular systolic and diastolic function, aortopulmonary collateral flow, and pulmonary vascular resistance during dobutamine stress. Key findings were that dobutamine resulted in increased collateral flow and pulmonary flow with a reduction in pulmonary vascular resistance. Despite increased contractility as defined by the end-systolic pressure-volume ratio (ESPVR), stroke volume did not increase. Ventricular compliance was diminished. Although these findings might not be generalizable to all Fontan patients, they provide important insights into the complex pathophysiology of the failing Fontan circulation. 15
Cardiac Magnetic Resonance Imaging for Noninvasive Assessment of Cardiovascular Disease During the Follow-Up of Patients With Kawasaki Disease
Summary: Kawasaki disease (KD) was first reported 40 years ago in Japan and is the most important cause of acquired heart disease in childhood. This acute pediatric vasculitis is associated with the development of coronary artery aneurysms that may cause myocardial ischemia and infarction at a young age. In 2004, the American Heart Association published guidelines for the follow-up of patients with KD. Echocardiography is recommended for routine coronary artery surveillance, but it can only visualize the proximal coronary arteries and becomes progressively more difficult as a child grows. Coronary artery lesions, therefore, can be missed when relying on echocardiography only. According to the guidelines, nuclear stress testing and conventional coronary angiography are advised for patients with KD with persistent coronary artery aneurysms but carry risks associated with radiation exposure and the invasive nature of angiography. Cardiac magnetic resonance is a noninvasive and radiation-free imaging modality that overcomes these disadvantages. The present study applied a comprehensive cardiac magnetic resonance protocol during the follow-up of 63 patients with KD aged ≥8 years to detect coronary artery aneurysms, reversible ischemia, and myocardial infarction, all in 1 procedure. The results support cardiac magnetic resonance as a safe and informative imaging modality to identify coronary artery aneurysms (including lesions missed by prior echocardiography), ischemia, and myocardial infarction in a single imaging procedure. As a safe, noninvasive, and radiation-free imaging method for coronary artery surveillance, cardiac magnetic resonance warrants consideration for incorporation in future guidelines for long-term follow-up of patients with KD.
Conclusions:
A comprehensive cardiac magnetic resonance imaging protocol including adenosine stress testing is feasible to identify coronary artery pathology, ischemia, and myocardial infarction in former patients with KD and compares favorably with echocardiography. cardiac magnetic resonance imaging may be used as a noninvasive and radiation-free imaging method for coronary artery surveillance during the long-term follow-up of patients with KD.
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Editor's Comment: This study of 63 patients (≥8 years) with KD tests the hypothesis that cardiac magnetic resonance imaging with adenosine stress might complement the currently recommended approach to follow-up of Kawasaki patients that includes echocardiography, as well as nuclear perfusion imaging and coronary angiography in selected patients. The results are promising, particularly because of the desirability of avoiding radiation exposure in this patient group. As might be expected, cardiac magnetic resonance imaging detected some coronary artery aneurysms not seen on echocardiography because these lesions may be distal to the coronary segments most reliably seen with echo. However, it remains to be shown that the technique performs adequately against a coronary angiographic gold standard. 16
X-Ray Magnetic Resonance Fusion to Internal Markers and Utility in Congenital Heart Disease Catheterization
Summary: Fluoroscopy is the main imaging modality used to guide catheterization procedures. However, several limitations including poor soft tissue definition, the use of ionizing radiation, and lack of 3-dimensional (3-D) data make this imaging modality suboptimal. In the x-ray magnetic resonance fusion (XMRF) modality, 3-D magnetic resonance imaging data are overlaid onto live fluoroscopic images during the catheterization procedure. This takes advantage of the high spatial and temporal resolution provided by fluoroscopy and the good soft tissue 3-D anatomic information provided by magnetic resonance imaging. However, to date, there has been no simple method to overlay magnetic resonance imaging data onto fluoroscopy data. Current XMRF technology requires the use of external fiducial markers, specialized x-ray systems, or 3-D rotational radiocontrast runs, which makes it impractical to perform XMRF on a routine clinical basis. The authors report on a new XMRF method that can now be done quickly with commercially available software, without the need for contrast, customized x-ray systems, or external fiducial markers. Furthermore, the method only uses minimal radiation, making it feasible to routinely perform XMRF during catheterization procedures. The authors have used this modality during congenital heart disease catheterization in 23 patients. They have found XMRF useful for roadmapping, angiographic camera angle selection, and for device positioning. This catheterization modality has the potential to significantly reduce radiation exposure and improve catheterization outcomes.
Conclusions: Internal marker-based registration can be performed quickly, with minimal radiation, without the need for contrast, and with clinically acceptable accuracy using commercially available software. The authors have also demonstrated several potential uses for XMRF in routine clinical practice.
Editor's Comment: This study provides data on the use of XRMF during the catheterization of 23 patients (0.4-43.8 years) with complex congenital heart disease. With XRMF, 3-D cardiac magnetic resonance imaging data are overlaid onto live fluoroscopic images taking advantage of the high spatial and temporal resolution of fluoroscopy and the good soft tissue 3-D anatomic information provided by magnetic resonance imaging. This small study suggests that XRMF may be helpful in road mapping invasive procedures, selecting fluoroscopic camera angles, and assisting in device positioning, thus potentially reducing the radiation exposure and improving catheterization outcomes in complex congenital procedures. 17
Mitral and Tricuspid Annular Velocities Before and After Pericardiectomy in Patients With Constrictive Pericarditis
Summary: The diagnosis of constrictive pericarditis is often challenging even after multiple diagnostic tests. Tissue Doppler imaging of the mitral annulus has facilitated the identification of constriction, which potentially is curable by pericardiectomy. Preserved or augmented medial annulus early diastolic velocity in a patient with heart failure and normal ejection fraction points to the diagnosis of constriction. However, this finding is not that helpful in young patients who normally have preserved early diastolic mitral annulus velocity. The additional finding of lower mitral lateral annulus early diastolic velocity compared with the medial annulus increases confidence in the diagnosis of constriction. Although normal or increased mitral medial annulus velocity strongly suggests the diagnosis of constriction, it may be reduced if there is superimposed myocardial disease. Even in this situation, the mitral lateral annulus velocity is usually lower than that at the medial annulus. The fact that annular velocities return to lower values after pericardiectomy confirms that the characteristic annulus velocity pattern observed is a product of constrictive pericardium. We need to take advantage of this simple measurement when evaluating a patient with heart failure and normal left ventricular ejection fraction.
Conclusions:
The mitral lateral/medial e′ ratio is reversed in three fourths of patients with constrictive pericarditis (CP). All annular velocities are lower in secondary compared with primary CP before pericardiectomy. After pericardiectomy, there is reduction of all annular velocities and normalization of the mitral lateral/medial e′ ratio.
Editor's Comment: The diagnosis of constrictive pericarditis remains challenging despite the identification of multiple noninvasive imaging features of this condition. This study suggests that the finding of reversed mitral annular lateral e′ to mitral annular medial e′ ratio (medial e′≥lateral e′) is a common finding in constriction with a tendency to normalization after successful pericardiectomy. This may provide another tool in the differentiation between constrictive and restrictive physiology. Although the authors also describe differences in tricuspid and mitral annular velocities between patients with primary (idiopathic) versus secondary (radiation/surgery) constriction, the clinical impact of these findings is less certain. 18
Quantification of Regional Myocardial Oxygenation by Magnetic Resonance Imaging: Validation With Positron Emission Tomography
Summary: Myocardial ischemia manifests as an imbalance between myocardial oxygen supply and demand. Cardiac positron emission tomography (PET) is currently the only imaging modality for absolute quantification of regional myocardial perfusion with 15 O-water and oxygen metabolism with 11 carbon-acetate. However, the use of PET in this setting is limited because of its low spatial resolution (not suitable for the detection of subendocardial perfusion defects), relatively long acquisition time, limited availability, relative high cost, and ionizing radiation. However, magnetic resonance imaging (MRI) is a noninvasive imaging modality that is widely available, provides excellent image spatial resolution and soft-tissue contrast, and does not require iodinated contrast media or ionizing radiation. In the present study, the technique for assessing myocardial oxygenation was validated against gold standard PET measurements in a large animal model in a clinical 1.5-T MRI scanner. With the rapid image acquisition used in this study, it is possible to integrate these methods with other established cardiac MRI approaches, such as perfusion, myocardial cine, and even delayed enhancement for characterizing ischemic myocardial tissue. This nonradiation method also allows for consecutive monitoring of the myocardium's dose responses to various therapeutic interventions. Although this MR technique was validated with altered myocardial oxygen status caused by upstream coronary artery stenosis, this method may potentially be used to assess change in myocardial oxygen consumption due to other generalized disease conditions such as hypertension, diabetes mellitus, cardiomyopathies, and valvular heart disease.
Conclusions: Cardiac MRI methods may provide an alternative to radionuclide imaging in settings of myocardial ischemia. The authors' newly developed quantitative MRI oxygenation imaging technique may be a valuable noninvasive tool to directly evaluate myocardial energetics and efficiency.
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Editor's Comment: This animal study, using a canine model of epicardial coronary stenosis, provides preliminary information that cardiac magnetic resonance imaging may provide an alternative to PET as a noninvasive method for quantitating regional myocardial perfusion. MRI-assessed myocardial blood flow, myocardial oxygen consumption, and oxygen extraction fraction correlated acceptably with PET gold standards. Should the feasibility of this approach be confirmed in human studies, this cardiac magnetic resonance imaging method would be appealing given its potentially superior spatial resolution and avoidance of ionizing radiation. 19
Clinical Value of Absolute Quantification of Myocardial Perfusion With 15 O-Water in Coronary Artery Disease
Summary: The standard interpretation of perfusion imaging is based on the assessment of relative perfusion defects. This approach has limitations, particularly in the detection of multivessel disease and microvascular dysfunction. Using positron emission tomography, it is possible to overcome these handicaps by measuring myocardial blood flow in absolute terms. The authors investigated 104 patients with a moderate (30-70%) pretest likelihood of coronary artery disease. The patients underwent positron emission tomography during adenosine stress using 15 O-water and dynamic imaging. Absolute myocardial blood flow was calculated from which both standard relative uptake images and images exhibiting quantitative myocardial blood flow were produced. The patients and the main vessel regions were then classified as normal or abnormal and compared against the reference of conventional angiography with fractional flow reserve.
In patient-based analysis, the positive predictive value, negative predictive value, and accuracy of quantitative blood flow in the detection of obstructive coronary artery disease were 86, 97, and 92%, respectively. The corresponding values with relative uptake analysis were 61, 83, and 73%, respectively. In region-based analysis, the receiver operating characteristic curves confirmed that the absolute quantification was superior to relative assessment. In particular, the specificity and positive predictive value were low using just relative differences in flow. Only 9 of 24 patients with 3-vessel disease were correctly assessed using relative analysis.
Conclusions:
The measurement of myocardial blood flow in absolute terms has a significant impact on the interpretation of myocardial perfusion. As expected, multivessel disease is more accurately detected.
Editor's Comment: This human study (n=104) with an angiographic reference standard uses adenosine-stress positron emission tomography imaging to assess both absolute and relative blood flow in patients with intermediate pretest probability of coronary disease. The authors report that the absolute blood flow approach has superior positive and negative predictive value and predictive accuracy to the relative blood flow technique for the diagnosis of epicardial coronary disease and that this approach performs better in a regional analysis as well. The positron emission tomography approach to assessing absolute blood flow appears particularly promising for patients with multivessel disease although the number (n=24) included in the current study was small. The value of this technique in detecting microvascular disease remains to be studied. 20
Rapid Detection of Coronary Artery Stenoses With Real-Time Perfusion Echocardiography During Regadenoson Stress
Summary: This study demonstrated that real-time myocardial contrast echocardiography could accurately detect myocardial perfusion abnormalities due to coronary artery disease after a bolus injection of the selective A2A receptor agonist regadenoson. Nearly all perfusion abnormalities could be visualized with real-time myocardial contrast echocardiography within the first 2 minutes of the bolus injection, with higher sensitivity than that obtained with wall motion. No significant side effects occurred after regadenoson bolus injection. These findings indicate that regadenoson real-time myocardial contrast echocardiography appears to be a feasible, safe, and rapid noninvasive method for the detection of significant coronary artery stenoses. Unlike radionuclide imaging, no ionizing radiation is required, and the results are available to the physician and patient immediately. Although further multicenter clinical investigation is needed, the use of real-time myocardial contrast echocardiography with regadenoson may be an important alternative pharmacological stress echocardiography test in the future.
Conclusions: Regadenoson real-time myocardial contrast echocardiography appears to be a feasible, safe, and rapid noninvasive method for the detection of significant coronary artery stenoses.
Editor's Comment: The accurate detection of obstructive coronary artery disease remains one of the most important concerns in cardiovascular medicine, and the incremental value of imaging for such has been demonstrated in appropriate subsets of patients referred for stress testing. Nuclear techniques have traditionally been relied upon for stress myocardial perfusion imaging, with increasing interest in nonirradiating modalities such as echocardiography and magnetic resonance. Porter et al tested the ability of perfusion imaging with contrast-enhanced echocardiography during administration of the selective A2 adenosine receptor agonist regadenoson to accurately detect obstructive coronary artery disease in 100 patients undergoing invasive angiography. With an overall accuracy of 78% in a fairly obese cohort, these results may foster greater consideration of contrast echocardiography as a viable myocardial perfusion imaging modality. 21
Predictive Value of Multislice Computed Tomography Variables of Atherosclerosis for Ischemia on Stress-Rest Single-Photon Emission Computed Tomography
Summary: Recently, multislice computed tomography (MSCT) cardiac imaging has been increasingly applied for the evaluation of patients presenting with suspected coronary artery disease. The reported high negative predictive values of almost 100% designates MSCT as a particularly effective technique for ruling out the presence of obstructive coronary artery disease. Accordingly, if patients show normal coronary arteries on MSCT angiography, further testing is not required, whereas if atherosclerotic disease has been verified on MSCT, unfortunately no information is provided on the hemodynamic relevance. As a result, the decision as to which patient requires further functional testing or direct invasive evaluation with potential revascularization currently remains largely dependent on individual interpretation of the coronary arteries on MSCT angiography, combined with pretest likelihood and clinical judgment. Preferably, more information than merely the presence of luminal narrowing is required from this technique. In this study, several MSCT variables of atherosclerosis were identified that were associated with a higher likelihood of ischemia. Moreover, integration of all MSCT variables of atherosclerosis significantly improved prediction of the presence of ischemia on myocardial perfusion imaging. Possibly, these results may allow a more refined and individualized assessment of patients undergoing MSCT angiography and provide the basis for the development of an algorithm to improve identification of patients requiring more aggressive therapy or intervention.
Conclusions: In addition to the degree of stenosis, MSCT variables of atherosclerosis describing plaque extent, composition, and location are predictive of the presence of ischemia on myocardial perfusion imaging.
Editor's Comment: Cardiac computed tomography carries an undisputable advantage over other noninvasive cardiovascular imaging modalities in its ability to provide high-resolution coronary
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angiography. Furthermore, it offers significant information regarding coronary atherosclerotic plaque that is typically not provided by invasive x-ray angiography. In a remarkably large cohort undergoing both coronary computed tomography angiography and rest/stress myocardial perfusion imaging using single-photon emission computed tomography, van Velzen et al analyzed computed tomography features of plaque including calcification, stenosis, plaque extent, and plaque location. Ischemia by single-photon emission computed tomography was more likely in the setting of greater stenosis but also in the presence of greater plaque extent and more proximal plaque location. It is likely that this work will spur increased interest in coupling stenosis detection with quantitative plaque classification by computed tomography angiography. 22
Comparison Between Ultrafast and Standard Single-Photon Emission Computed Tomography in Patients With Coronary Artery Disease: A Pilot Study
Summary: This pilot study compared the diagnostic accuracy of myocardial perfusion imaging assessed by ultrafast (UF) single-photon emission computed tomography (SPECT) and standard (S) SPECT in a population of patients undergoing coronary or computed tomography angiography. The authors evaluated regional myocardial ischemia in a head-to-head comparison using qualitative and quantitative analysis. On a per-patient basis, these results showed similar diagnostic accuracy between the 2 approaches. On a per-vessel analysis, UF-SPECT resulted in a higher sensitivity for identifying obstructive coronary artery disease (CAD) than S-SPECT. Consequently, UF-SPECT resulted in a more-accurate delineation of multivessel CAD. If confirmed in larger studies, these findings may have important implications for diagnosis and for risk stratification of patients with known or suspected CAD.
Conclusions:
This pilot study confirms that UF-SPECT provides high-quality fast myocardial perfusion imaging and suggests that it may allow a more-accurate evaluation of both extent and severity of myocardial ischemia in patients with CAD.
Editor's Comment: Although other modalities clamor to detect CAD with sufficient accuracy but without radiation, SPECT continues to advance in its ongoing efforts to reduce radiation dose while maintaining diagnostic appeal. A major step forward in this regard has been the development of a novel collimation configuration that delivers increased photon sensitivity for the same dose of radiopharmaceutical administered. Gimelli et al tested this UF platform against standard SPECT, and showed similar detection of CAD but higher sensitivity at the pervessel level and in the detection of multivessel disease. Such advances further the value of SPECT-based myocardial perfusion imaging for cardiac stress testing. 23
Heterogeneity of Intramural Function in Hypertrophic Cardiomyopathy: Mechanistic Insights From MRI Late Gadolinium Enhancement and High-Resolution Displacement Encoding With Stimulated Echoes Strain Maps
Summary: Magnetic resonance imaging can define the anatomic extent of hypertrophy, global ventricular function, and regional wall thickening, with cine magnetic resonance imaging providing highquality information comparable to 2-diamensional and 3-diamensional echocardiography. Displacement encoding with stimulated echoes (DENSE) is an magnetic resonance imaging-specific method for quantifying myocardial strain with physics intrinsically similar to myocardial tagging methods but at higher resolution. DENSE allows quantification of both in-plane directions of motion and, although not implemented in this study, also through plane motion, and minimizes artifacts caused by through-plane motion of tissue. Late gadoliniumenhanced MRI can detect myocardial fibrosis. These methods were used in the current study to examine the intramural relationship between fibrosis and regional contractile function in 22 patients with hypertrophic cardiomyopathy. Intramural systolic strain by DENSE was significantly depressed within areas of confluent and diffuse late gadolinium enhancement, but also in the core of the most hypertrophic nonenhanced segment. DENSE demonstrated an unexpected inner rim of largely preserved contractile function and a noncontracting outer wall within hypertrophic segments in 91% of patients. These observations indicate that we should not consider hypertrophic myocardium as a uniform mass. Instead, the myocardium has a heterogeneous nature that is not surprising, considering the heterogeneous abnormalities seen in pathological studies. Late gadolinium enhancement (LGE) imaging of fibrosis predicted some but not all of the heterogeneity of intramural contractile abnormalities. This indicates that myocardial scarring or excess interstitial collagen deposition does not fully explain the observed contractile heterogeneity in hypertrophic cardiomyopathy. Thus, myofibril disarray or other nonfibrotic processes affect systolic function in a large number of patients with hypertrophic cardiomyopathy.
Conclusions:
LGE predicted some but not all of the heterogeneity of intramural contractile abnormalities. This indicates that myocardial scarring or excess interstitial collagen deposition does not fully explain the observed contractile heterogeneity in hypertrophic cardiomyopathy (HCM). Thus, myofibril disarray or other nonfibrotic processes affect systolic function in a large number of patients with HCM.
Editor's Comment: Despite the time-tested value of using clinical risk predictors in patient with HCM, limitations of this approach are apparent when trying to explain a sudden death event in an HCM patient without such predictors.
LGE cardiac magnetic resonance has demonstrated added value in HCM risk prediction, but it may only be visually apparent when the disease is advanced. Aletras et al started from the recognition that myocyte disarray may occur without fibrosis in the HCM heart, noting that this disarray should negatively impact contractile function. They showed in a cohort of patients with HCM that careful measurement of myocardial strain detected changes in regions where abnormality by LGE cardiac magnetic resonance was not apparent. Further prospective studies are warranted to test the incremental predictive value of such measurements in patients with HCM. 24
A Simultaneous X-Ray/MRI and Noncontact Mapping Study of the Acute Hemodynamic Effect of Left Ventricular Endocardial and Epicardial Cardiac Resynchronization Therapy in Humans
Summary: The absence of clinical response in 30 to 40% of patients receiving cardiac resynchronization therapy poses a great challenge to heart failure clinicians and device implanters. It is well documented that positioning of the left ventricular (LV) lead in areas of myocardial scar in patients with ischemic cardiomyopathy is associated with a diminished response to cardiac resynchronization therapy (CRT). Regions of slow conduction exist in both nonischemic and ischemic cardiomyopathy that can be delineated using noncontact mapping, whereby the electrophysiological properties of a chamber can be characterized using a multielectrode array. Using this technique, the authors evaluated the effect of pacing inside and outside regions of slow conduction on acute hemodynamic response to CRT. Procedures were performed in a combined x-ray and magnetic resonance imaging (MRI) environment so that tissue characterization by delayed-enhancement cardiac magnetic resonance imaging could be correlated with electrophysiological assessment. Both endocardial and transvenous epicardial LV pacing were performed e48 Circ Cardiovasc Imaging July 2012
with the hypothesis that endocardial pacing may be more effective as a result of reproducing the physiological pattern of activation of the LV myocardium, as well as lack of constraint by the coronary venous anatomy. The authors found that zones of slow conduction could be identified using delayed-enhancement cardiac magnetic resonance in patients with an ischemic heart failure etiology, but not in nonischemic cardiomyopathy. The acute effect of CRT was superior in response to endocardial compared with epicardial pacing. Stimulation within zones of slow conduction was associated with a diminished response to CRT. This is a potential explanation for lack of response to CRT and reinforces the need for positioning the LV lead on an individual basis.
Conclusions:
Endocardial LV pacing appears superior to conventional CRT, although the optimal site varies between subjects and is influenced by pacing within areas of slow conduction. Delayedenhancement cardiac magnetic resonance was a poor predictor of zones of slow conduction in nonischemic patients.
Editor's Comment: Important questions remain in the ongoing search for optimal cardiac resynchronization, such as where one should pace the LV for maximum benefit. Late gadolinium enhancement cardiac magnetic resonance has also been posited as a modality that could potentially not only guide patient selection but also direct lead placement away from sites with evident scar. Ginks et al performed a small but careful hemodynamic study with LGE acquisition before pre-and post-LV pacing using a hybrid system that allowed for registration of magnetic resonance with noncontact mapping data. Invasive LV pressure measurement demonstrated the greatest benefit with LV endocardial versus epicardial pacing. Furthermore, late gadolinium enhancement-positive regions in patients with ischemic cardiomyopathy predicted zones of slow conduction by noncontact mapping. As one might expect, LGE performed less well in patients with nonischemic cardiomyopathy. Techniques such as T1 mapping warrant consideration as potentially superior method to detect more diffuse, interstitial fibrosis that likely contributes to substrate for poor CRT response in nonischemic myocardial diseases. 25
Dyssynchrony, Contractile Function, and Response to Cardiac Resynchronization Therapy
Summary: Although cardiac resynchronization therapy (CRT) has been shown to reduce cardiovascular outcomes in patients with heart failure and left ventricular dysfunction, almost one third of patients who receive CRT do not respond to treatment. Determining which patients are more or less likely to benefit from CRT remains a therapeutic challenge. Left ventricular mechanical dyssynchrony has been suggested as a method for overcoming the limitations of estimating electric dyssynchrony. Echocardiographic assessments of both left ventricular mechanical dyssynchrony and discrete contractile function, which can reflect the extent of myocardial viability and scar burden, now can be performed in a highly reproducible and angleindependent manner by using speckle-tracking analysis. Therefore, in a sample of 1077 patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial-CRT Trial, we used echocardiographic myocardial deformation analyses to investigate whether or not mechanical synchrony and contractility might predict response to CRT. The authors observed that the combination of mechanical dyssynchrony and preserved contractile function significantly predicted lower risk for recurrent heart failure or death after CRT, even after adjusting for factors conventionally associated with CRT response.
These results indicate that the ventricle must be dyssynchronous but also viable, as reflected by contractile function, to benefit from CRT. These findings suggest that mechanical dyssynchrony and contractile function may be more directly related to clinical response and outcomes than conventionally measured electric dyssynchrony. The analyses were strengthened by the availability of a large sample size, data on long-term clinical outcomes, and the presence of a control group that allowed estimation of the treatment effect.
Conclusions: Both mechanical dyssynchrony and contractile function are important independent correlates of benefit from CRT.
Editor's Comment: CRT offers significant quality and quantity of life improvement for the 70% of patients with heart failure deemed "responders" postdevice placement. Uncertainties remain regarding (1) the best way to identify nonresponders before device placement and (2) refined selection of heart failure patients most likely to benefit from CRT. Knappe et al added strain measurement to the preimplant echocardiography protocol, building on prior disappointing studies that called into question the ability of dyssynchrony measures to reduce such uncertainty. In a substudy of the MADIT-CRT trial, they demonstrated incremental value of combining dyssynchrony with global longitudinal strain measurement to predict CRT response. Those with left bundle branch block continued to derive the greatest benefit, suggesting that electrocardiographic measures plus refined analyses of cardiac deformation may improve referral for CRT to maximize benefit while optimizing utilization of this therapeutic technology. 26
Right Ventricular Response to Intensive Medical Therapy in Advanced Decompensated Heart Failure
Summary: Right ventricular (RV) systolic function generally is recognized as an important determinant of outcome in patients with heart failure, but its quantitative assessment is limited by the complex RV geometry. This study sought to evaluate the effect of intensive medical therapy on RV performance in patients admitted to the hospital with advanced decompensated heart failure, using both conventional RV echocardiographic indices and 2-diamensional strain analysis of the RV free wall. RV peak systolic strain was measured as the average peak longitudinal strain of the basal, mid, and apical segment of the RV free wall shortly after admission and 48 to 72 hours later. Not baseline RV function, but rather a dynamic improvement in RV mechanics (defined as an absolute increase in RV peak systolic strain after 48-72 hours) in response to intensive medical therapy was found to be associated with lower long-term adverse events in this study population. These results suggest that in the setting of acute heart failure, it may be important to see the return to a more normal hemodynamic profile also reflected by an improvement in RV mechanics. Future research should determine whether an acute response of RV function to intensive medical therapy is eventually sustained at a much longer follow-up.
Conclusions: Dynamic improvement in RV mechanics in response to intensive medical therapy was associated with lower long-term adverse events in patients with acute decompensated heart failure than in patients not showing improvement.
Editor's Comment: The negative impact of abnormal RV function is apparent when faced with decision-making for patients with advanced decompensated heart failure. Medical therapy continues while patients await decisions on mechanical support or transplantation, but response to such medical therapy is infrequently predictable. Verhaert et al studied RV function using various echocardiography-based indices, and found that lack of improvement in RV peak systolic strain predicted adverse outcomes after a mean follow-up duration of 7.5 months. This work offers the sickest decompensated heart failure patients and their clinicians the promise of a tool that could help determine who is likely to respond to intensified medical therapy alone versus who should be considered earlier for more complex heart failure interventions. 27 The Editors
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Dyssynchrony Indices to Predict Response to Cardiac Resynchronization Therapy: A Comprehensive Prospective Single-Center Study
Summary: Multiple small retrospective studies suggested that various echocardiographic dyssynchrony indices have high sensitivity and specificity for identifying patients with a favorable response to cardiac resynchronization therapy (CRT). However, the multicenter prospective predictors of response to CRT trial was unable to identify any echocardiographic dyssynchrony parameter that added significant incremental value to the current simple QRS duration and clinical selection criteria for CRT. That study was criticized on the basis of its multicenter format and low reproducibility of many of the studied indices. In the current single-center study, 131 patients with wide QRS and left ventricular ejection fraction <35% had 6-month follow-up after CRT implantation. Fourteen dyssynchrony indices were evaluated for prediction of reverse remodeling (end-systolic volume reduction ≥15%). Overall, only indices using M-mode, tissue Doppler strain, and total isovolumic time had a receiver operating characteristic area under the curve greater than the line of no information, but none of these were strongly predictive of reverse remodeling. Thus, this prospective single-center study confirmed the predictors of response to CRT trial's conclusion and does not support a routine use of any echocardiographic dyssynchrony index to select patients for CRT. Echocardiographic selection of patients may in fact deny this potentially effective therapy to patients who could benefit from CRT. Future investigations should focus on further characterizing the clinical and laboratory features of the patients who do not respond to CRT.
Conclusions: These findings are consistent with the Predictors of Response to CRT study and do not support use of these dyssynchrony indices to guide use of CRT.
Editor's Comment: This study is complementary to the Predictors of Response to CRT trial (PROSPECT), addressing some of the remaining questions about echocardiography methodology of measurements of mechanical dyssynchrony and clinical outcomes. The study confirms the results of PROSPECT to CRT in that none of the indices achieved clinically relevant predictive value. At the heels of this study comes the extension of CRT recommendations to New York Heart Association (NYHA) class II patients; it appears even more important to develop and test alternative diagnostic tests able to accurately identify patients who will benefit from CRT. 28
Long-Term Anabolic-Androgenic Steroid Use Is Associated With Left Ventricular Dysfunction
Summary: Well over 1 million Americans, most of them men, have used illicit anabolic-androgenic steroids (AAS) to gain muscle mass for athletic purposes or simply to enhance personal appearance. Because illicit AAS use did not become widespread in the general population until the 1980s, it is only now that the first large wave of long-term illicit AAS users is approaching middle age. Preliminary data suggest that long-term exposure to supraphysiologic doses of AAS has cardiotoxic effects, but the nature and severity of these effects remain inadequately characterized. This study compared 12 long-term AAS users and 7 age-matched weightlifters who reported similar exercise levels but no AAS use. The AAS group showed striking impairments of cardiac contraction and relaxation (systolic and diastolic function) similar to that observed in well-established forms of cardiomyopathy. In particular, the AAS users showed markedly reduced left ventricular systolic function (lower left ventricular ejection fraction, longitudinal strain, and radial strain) and impaired left ventricular diastolic function (reduced early peak tissue velocity and ratio of early-to-late diastolic filling) compared with nonusers. These findings suggest that long-term AAS use may be associated with clinically relevant cardiac dysfunction and that AAS use should be considered as a potential cause of cardiomyopathy.
Conclusions: Cardiac dysfunction in long-term AAS users appears to be more severe than previously reported and may be sufficient to increase the risk of heart failure.
Editor's Comment: AAS use is on the rise among nonprofessional athletes. This study provides initial insights into the cardiac effects of long-term AAS and demonstrates that all indices of diastolic and systolic left ventricular dysfunction are impaired with AAS as compared with controls. The results are remarkably useful considering the many difficulties and hurdles to access this population and the severity of left ventricular dysfunction found. Further research assessing structural changes of the myocardium as well as coronary artery disease will complement these findings and would provide a comprehensive assessment of adverse cardiac effects of AAS. 29
Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
Summary: Heart failure with normal ejection fraction (HFNEF) can be diagnosed in ≈50% of patients with the clinical syndrome of HF. Nevertheless, the HFNEF syndrome seems to be heterogeneous and therefore will present with different pathologies leading to the disease. It is assumed that an accumulation of cardiac collagen is 1 important mediator in the development of HFNEF. The authors show here that increased transendothelial migration of inflammatory cells triggers a profibrotic phenotype by activating fibroblasts into myofibroblasts in cardiac tissue. Activated myofibroblasts, characterized by α-smooth muscle actin, are well known for excessive collagen production in other diseased tissues and express significantly more collagen compared with normal cardiac fibroblasts. Moreover, inflammatory cells reduced the expression of the collagen degradation system, the matrix metalloproteinases, again promoting cardiac fibrosis as 1 trigger for a stiff and noncompliant ventricle. This transdifferentiation was induced by transforming growth factor-β, which was expressed by inflammatory monocytes in the heart. Interestingly, the authors document here that these inflammatory cells can be found more frequently in cardiac tissue of the HFNEF group than in the control group. Therefore, continuous low-grade inflammation might be 1 key player in the development or progression of HFNEF. This would make antiinflammatory strategies inhibiting transendothelial migration of cells into the cardiac tissue an interesting approach in treating HFNEF, a disease plagued by limited data.
Conclusions: Cardiac inflammation contributes to diastolic dysfunction in HFNEF by triggering the accumulation of extracellular matrix.
Editor's Comment: Heart failure despite normal ejection fraction may develop due to an increase in cardiac inflammation, triggering cardiac collagen accumulation by inducing collagen gene expression and inhibiting the cardiac degradation system. This hypothesis is supported from evidence of this study reporting that cardiac inflammatory cells were found during endomyocardial biopsy together with extracellular remodeling with increased accumulation of collagen.
In a nifty combination of in vivo and cell culture experiments, the authors also demonstrated in cell culture experiments with primary cardiac fibroblasts derived from endomyocardial biopsy that inflammatory cells, which expressed the profibrotic growth factor transforming growth factor-β, trigger changes in extracellular matrix. The authors thus identified a potential therapeutic concept in HFNEF. 30
Impact of Coronary Plaque Morphology Assessed by Optical Coherence Tomography on Cardiac Troponin Elevation in Patients With Elective Stent Implantation
Summary: Mild elevations of cardiac troponin (cTn) occur frequently after percutaneous coronary intervention (PCI), and patients with e50 Circ Cardiovasc Imaging July 2012 elevated biomarkers after PCI have a worse prognosis. Few studies have shown a relationship between pre-PCI lesion subsets and post-PCI cTn levels in patients undergoing elective PCI. This issue has become of particular interest after the recent release of a new universal definition of myocardial infarction (MI) that defines a rise in cTn>3 times normal after PCI as a PCI-related MI. This study used optical coherence tomography (OCT) to study the relationship between pre-PCI plaque morphology and post-PCI cTnI elevations and followed outcomes to assess long-term event-free survival. One hundred and thirty-one patients with normal pre-PCI cTnI levels underwent OCT before nonemergency stent implantation. Post-PCI MI (31 patients, 23.7%) was associated with angiographic lesion length, type B2/C lesions, presence of thin-cap fibroatheroma, and fibrous cap thickness. In multivariable analysis, thin-cap fibroatheroma and type B2/C lesions were predictors of post-PCI MI. At a median follow-up of 12 months, cardiac event-free survival was significantly worse in patients with post-PCI MI (log-rank test χ 2 =8.9; P=0.003). Type B2/C lesions and the presence of OCT-defined thin-cap fibroatheroma can predict post-PCI MI in patients treated with elective stent implantation who may require adjunctive therapy after otherwise successful PCI.
Conclusions: Type B2/C lesions and the presence of OCT-defined thin-cap fibroatheroma can predict post-PCI MI in patients treated with elective stent implantation, who may require adjunctive therapy after otherwise successful PCI.
Editor's Comment: The association of thin-cap fibroatheroma or vulnerable plaques for future cardiovascular events is well documented. The current study provides support for the intriguing hypothesis that PCI of such lesions itself may be associated with worsened cardiovascular outcomes. Because rupture of the thin cap with protrusion of lipid and other plaque content through the stent strut's followed by distal embolization may at least partially explain this observation, tailoring stent design based on the extent and morphology of atherosclerosis may be an attractive research strategy with widespread clinical implications. 31
Magnetic Resonance-Guided Cardiac Interventions Using Magnetic Resonance-Compatible Devices: A Preclinical Study and First-in-Man Congenital Interventions
Summary: Magnetic resonance (MR)-guided diagnostic catheterizations for patients with congenital heart disease were pioneered in the authors' institution around a decade ago. However, performance of interventional procedures was still only made possible with the use of x-ray ionizing radiation either on its own or in combination with MR imaging guidance. Within that time period, several research workers performed MR-guided interventions in animals successfully, but translation into humans was not made possible because of the lack of complete MR-compatible devices. The emergence of a new MR-safe and compatible guide wire enabled the authors to perform the 2 first-in-man cardiac interventions reported here, solely under MR guidance. Future study will be needed to determine whether the outcomes for MR-guided procedures are comparable to those guided by fluoroscopy.
Conclusions:
The described preclinical study and case reports are encouraging that with the availability of the new MR-compatible and safe guide wire, certain percutaneous cardiac interventions will become feasible to perform solely under MR guidance in the future. A clinical trial is underway in the authors' institution. 
Integration of 3D Electroanatomic Maps and Magnetic Resonance Scar Characterization Into the Navigation System to Guide Ventricular Tachycardia Ablation
Summary: Currently, substrate-based catheter ablation for scarrelated ventricular tachycardia (VT) is based on obtaining a highdensity voltage map of the ventricle to identify low voltage areas indicative of scarred tissue and conducting channels (VT isthmus). This point-by-point mapping technique is time-consuming and has inherent technical limitations. Integration of scar anatomy from preprocedural imaging into a mapping system could facilitate the procedure. The present study shows that high-resolution 3D scar tissue reconstruction can be obtained by postprocessing 3T contrastenhanced cardiac magnetic resonance images and integrated and registered with the CARTO electroanatomic mapping system. Scar core and scar border zone are defined on the basis of relative signal intensity, and an algorithm obtaining the best agreement between contrast-enhanced cardiac magnetic resonance and the bipolar voltage maps is defined and appears to be improved by considering only the subendocardial half of the ventricular wall. Mapping and ablation findings and outcomes for a substrate-based VTablation using this technology is promising in this small series of patients. Therefore, although the technique is limited to nonimplantable cardioverterdefibrillator patients, future studies are warranted to determine whether this image-guided VT ablation method can improve the procedure.
Conclusions: Scar characterization by means of high-resolution contrast-enhanced (CE) cardiac magnetic resonance resembles that of electroanatomic voltage maps (EAM) and can be integrated into the CARTO system to guide VT ablation.
Editor's Comment: The boundary between scar and healthy myocardial tissue has been identified as the trigger zone for VT. This study demonstrates that magnetic resonance imaging LGE characteristics correlate well with electroanatomic mapping using the CARTO system. The study provides further reason to believe that success rates and efficiency and efficacy of VT ablation may increase if magnetic resonance imaging is used in a complementary manner providing preablation guidance. However, the exact mechanism in which magnetic resonance imaging will improve, facilitate, or change ablation procedures still needs to be determined. 33 
